pyrazines has been researched along with catechol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Cryns, VL; Messersmith, PB; Su, J | 1 |
| Hong, SY; Kang, S; Min, J; Moon, H; Shin, HH; Yang, HJ | 1 |
2 other study(ies) available for pyrazines and catechol
| Article | Year |
|---|---|
Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Catechols; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Molecular Structure; Polymers; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Structure-Activity Relationship | 2011 |
Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Capsid Proteins; Carcinoma, Hepatocellular; Catechols; Drug Delivery Systems; Humans; Liver Neoplasms; Nanocomposites; Pyrazines | 2014 |